PI3K/AKT/mTOR signaling regulates BCP ceramic-induced osteogenesis

被引:1
|
作者
Tan, Peijie [1 ]
Hua, Yuchen [1 ]
Yuan, Bo [1 ]
Liu, Xiaoyang [5 ]
Chen, Xuening [1 ]
Zeng, Wei-Nan [5 ]
Zeng, Qin [1 ,2 ,3 ,4 ]
Zhu, Xiangdong [1 ]
Zhang, Xingdong [1 ,2 ,3 ,4 ]
机构
[1] Sichuan Univ, Natl Engn Res Ctr Biomat, 29 Wangjiang Rd, Chengdu 610064, Peoples R China
[2] Sichuan Univ, NMPA Key Lab Qual Res & Control Tissue Regenerat B, Chengdu 610064, Peoples R China
[3] Sichuan Univ, Inst Regulatory Sci Med Devices, Chengdu 610064, Peoples R China
[4] Sichuan Univ, NMPA Res Base Regulatory Sci Med Devices, Chengdu 610064, Peoples R China
[5] Sichuan Univ, West China Hosp, Orthoped Res Inst, Dept Orthoped, Chengdu 610041, Peoples R China
基金
中国国家自然科学基金;
关键词
MESENCHYMAL STEM-CELLS; IN-VIVO; PATHWAY; DIFFERENTIATION; OSTEOBLAST; ROLES; PROLIFERATION; SUPPRESSION; EXPRESSION;
D O I
10.1039/d4tb01335b
中图分类号
TB3 [工程材料学]; R318.08 [生物材料学];
学科分类号
0805 ; 080501 ; 080502 ;
摘要
An increasing number of studies demonstrate that biphasic calcium phosphate (BCP) ceramics can induce bone regeneration. However, the underlying molecular mechanisms involved are still poorly understood. This work was proposed to investigate how PI3K/AKT/mTOR signaling influenced the osteogenesis mediated by BCP ceramics. The results showed that incubation with BCP ceramics promoted the proliferation of murine bone marrow-derived mesenchymal stem cells (BMSCs) in a time-dependent manner. The resulting cell proliferation was then suppressed by the selective inhibition of either PI3K, AKT, or mTOR signaling activation. Next, we confirmed that BCP ceramics up-regulated the phosphorylation levels of AKT and mTOR in BMSCs, suggesting the ability of BCP ceramics to drive the activation of PI3K/AKT/mTOR signaling in BMSCs. Furthermore, the blockade of PI3K/AKT/mTOR signaling prevented BCP ceramics-induced osteogenic differentiation and pro-angiogenesis of BMSCs by down-regulating the expression of genes encoding OPN, RUNX2 or VEGF. Moreover, the PI3K/AKT/mTOR signaling blockade suppressed stem cell infiltration and new bone formation in the implants following intra-muscular implantation of BCP ceramics in mice. Therefore, our results suggested that PI3K/AKT/mTOR signaling played a critical regulatory role in BCP ceramic-induced osteogenesis. BCP ceramics regulate PI3K/AKT/mTOR signaling for cell proliferation and osteogenic gene expression of BMSCs in vitro and new ectopic bone formation in the implanted ceramics in mice.
引用
收藏
页码:7591 / 7603
页数:13
相关论文
共 50 条
  • [21] PI3K/AKT/mTOR pathway regulates renal expression of Klotho
    Perez-Gomez, Aurora
    Tocados, Juan Miguel Diaz
    Coral, Juan Diego Dominguez
    Garcia-Carrasco, Alicia
    Caus, Maite
    Schanstra, Joost
    Del Bello, Arnaud
    Klein, Julie
    Valdivielso, Jose Manuel
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [22] PI3K/AKT signaling regulates bioenergetics in immortalized hepatocytes
    Li, Chen
    Li, Yang
    He, Lina
    Agarwal, Amit R.
    Zeng, Ni
    Cadenas, Enrique
    Stiles, Bangyan L.
    FREE RADICAL BIOLOGY AND MEDICINE, 2013, 60 : 29 - 40
  • [23] Targeting EGFR/PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma
    Bang, Jieun
    Jun, Mihyeon
    Lee, Soyun
    Moon, Hyuk
    Ro, Simon Weonsang
    PHARMACEUTICS, 2023, 15 (08)
  • [24] Targeting PI3K/AKT/mTOR Signaling Pathway in Breast Cancer
    Li, Huayi
    Prever, Lorenzo
    Hirsch, Emilio
    Gulluni, Federico
    CANCERS, 2021, 13 (14)
  • [25] TARGETING THE PI3K/AKT/MTOR SIGNALING PATHWAYS IN CYSTIC FIBROSIS
    Reilly, R.
    Mroz, M.
    Dempsey, E.
    Shields, S.
    Wynne, K.
    McKone, E. F.
    Hiebel, C.
    Behl, C.
    Coppinger, J.
    PEDIATRIC PULMONOLOGY, 2016, 51 : 200 - 200
  • [26] PI3K/AKT/mTOR Signaling and Differentiation of Human iPS Cells
    Cross, Alan
    Jaishankar, Amritha
    Brandon, Nicholas
    Wesolowski, Steve
    Burli, Roland
    Hoeppner, Dan
    Kim, Suel-Kee
    Seo, Seungmae
    Shin, Joo Heon
    Colantuoni, Carlo
    Chenoweth, Josh
    Weinberger, Daniel
    McKay, Ron
    NEUROPSYCHOPHARMACOLOGY, 2016, 41 : S541 - S542
  • [27] PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma
    Li, Xiaoman
    Wu, Changjing
    Chen, Nianci
    Gu, Huadi
    Yen, Allen
    Cao, Liu
    Wang, Enhua
    Wang, Liang
    ONCOTARGET, 2016, 7 (22) : 33440 - 33450
  • [28] Recent syntheses of PI3K/Akt/mTOR signaling pathway inhibitors
    Welker, Mark E.
    Kulik, George
    BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (14) : 4063 - 4091
  • [29] PI3K/AKT/mTOR Signaling Network in Human Health and Diseases
    Omolekan, Tolulope O.
    Chamcheu, Jean Christopher
    Buerger, Claudia
    Huang, Shile
    CELLS, 2024, 13 (17)
  • [30] The PI3K/AKT/mTOR signaling pathway in osteoarthritis: a narrative review
    Sun, K.
    Luo, J.
    Guo, J.
    Yao, X.
    Jing, X.
    Guo, F.
    OSTEOARTHRITIS AND CARTILAGE, 2020, 28 (04) : 400 - 409